Featured Research

from universities, journals, and other organizations

Anti-Inflammatory Drug Reduces Growth Of Cancerous Tumors In Rats

Date:
August 20, 2002
Source:
Johns Hopkins Medical Institutions
Summary:
Research led by a nurse investigator at Johns Hopkins has found that a pain reliever commonly used to treat serious and painful forms of arthritis may also reduce the growth of malignant tumors after cancer surgery. Indomethacin, a nonsteroidal anti-inflammatory drug, given to rats after surgery reduced tumor promotion by more than 50 percent, according to Gayle Page, associate professor at The Johns Hopkins University School of Nursing.

Research led by a nurse investigator at Johns Hopkins has found that a pain reliever commonly used to treat serious and painful forms of arthritis may also reduce the growth of malignant tumors after cancer surgery. Indomethacin, a nonsteroidal anti-inflammatory drug, given to rats after surgery reduced tumor promotion by more than 50 percent, according to Gayle Page, associate professor at The Johns Hopkins University School of Nursing. Her study results appear in the August issue of the Journal of Pain.

"These findings provide further support to our supposition that unmanaged pain is associated with potentially life-threatening consequences," says Page. "If our results in animals prove to be similar in humans, controlling postoperative pain and inflammation must become a priority in the management of cancer patients undergoing surgery," she adds.

Prior research in animals has shown that pain and surgical trauma suppress the immune system's natural killer (NK) cells, trigger an inflammatory response and significantly increase tumor development.

Page and her co-investigator at Tel Aviv University reasoned that the relatively strong anti-inflammatory action of indomethacin would therefore affect postoperative tumor growth.

"We have already tested other pain relievers, such as morphine and fentanyl, and shown that they provide some protection against the tumor-promoting effects of surgery, but these drugs are pain relievers without anti-inflammatory action," Page says. "So we chose to test indomethacin because it eases both pain and inflammation and is injectable, giving us control in its administration."

In the study, 124 anesthetized rats, without a tendency to grow tumors, were subjected to surgery, given indomethacin, and injected with cancer cells. After surgery, female rats had an overall 200 percent increase in lung tumor growth, and tumor growth in males increased by 350 percent. Two doses of indomethacin (either 1.5mg or 4.0 kg) reduced the tumor development in both males and females by up to 63 percent. The scientists also found that rats undergoing surgery showed suppressed NK activity, which was restored after receiving indomethacin. Rats of both sexes that got indomethacin also exhibited behavior suggesting abdominal discomfort was relieved.

The study was funded by the National Institute of Nursing Research at the National Institutes of Health. Shamgar Ben-Eliyahu, of the Tel Aviv University Department of Psychology, was also an author and supported by the National Cancer Institute at the National Institutes of Health.


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Anti-Inflammatory Drug Reduces Growth Of Cancerous Tumors In Rats." ScienceDaily. ScienceDaily, 20 August 2002. <www.sciencedaily.com/releases/2002/08/020820071620.htm>.
Johns Hopkins Medical Institutions. (2002, August 20). Anti-Inflammatory Drug Reduces Growth Of Cancerous Tumors In Rats. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2002/08/020820071620.htm
Johns Hopkins Medical Institutions. "Anti-Inflammatory Drug Reduces Growth Of Cancerous Tumors In Rats." ScienceDaily. www.sciencedaily.com/releases/2002/08/020820071620.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins